12 | Pharmaceutical PreparationsIBA
03/2021
-
02/2005 |
11 | Proteasome InhibitorsIBA
01/2020
-
08/2012 |
9 | carfilzomibIBA
01/2020
-
08/2012 |
9 | Proteasome Endopeptidase Complex (Proteasome)IBA
11/2019
-
12/2011 |
8 | Peptides (Polypeptides)IBA
12/2021
-
08/2007 |
6 | Bortezomib (Velcade)FDA Link
03/2021
-
12/2011 |
4 | AnionsIBA
05/2015
-
01/2008 |
3 | CyclodextrinsIBA
11/2019
-
01/2017 |
3 | AlbuminsIBA
01/2019
-
01/2018 |
3 | PolymersIBA
10/2018
-
11/2015 |
3 | Irinotecan (Camptosar)FDA LinkGeneric
01/2015
-
11/2012 |
3 | 1,1'- ((propane- 1,3- diyl)dioxy)bis(7- methoxy- 2- methylidene- 1,2,3,10,11,11a- hexahydro- 5H- pyrrolo(2,1- c)(1,4)benzodiazepin- 5,11- dione)IBA
06/2011
-
01/2008 |
2 | Quinic Acid (Quinate)IBA
01/2020
-
12/2018 |
2 | Carrier Proteins (Binding Protein)IBA
01/2019
-
10/2018 |
2 | Paclitaxel (Taxol)FDA LinkGeneric
12/2018
-
08/2012 |
2 | LigandsIBA
12/2018
-
04/2014 |
2 | Drug CarriersIBA
12/2018
-
01/2018 |
2 | DNA (Deoxyribonucleic Acid)IBA
03/2017
-
06/2011 |
2 | Cyclin D1IBA
01/2016
-
04/2014 |
2 | Bile Acids and Salts (Bile Acids)IBA
04/2014
-
01/2011 |
2 | Solute Carrier Organic Anion Transporter Family Member 1B3IBA
01/2013
-
01/2008 |
1 | Amyloid (Amyloid Fibrils)IBA
12/2021 |
1 | InterferonsIBA
11/2019 |
1 | UbiquitinIBA
11/2019 |
1 | Hydroxyl RadicalIBA
01/2019 |
1 | erucylphosphocholineIBA
01/2019 |
1 | ixazomibIBA
01/2019 |
1 | Polylactic Acid-Polyglycolic Acid CopolymerIBA
12/2018 |
1 | Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric
12/2018 |
1 | SelectinsIBA
12/2018 |
1 | Scavenger Receptors (Scavenger Receptor)IBA
10/2018 |
1 | Dopamine (Intropin)FDA LinkGeneric
10/2018 |
1 | Docetaxel (Taxotere)FDA Link
01/2018 |
1 | formaldehyde-serum albuminIBA
01/2018 |
1 | Albumin-Bound PaclitaxelFDA Link
01/2018 |
1 | MethyltransferasesIBA
03/2017 |
1 | VorinostatFDA Link
03/2017 |
1 | Histone Deacetylases (Histone Deacetylase)IBA
03/2017 |
1 | Testosterone (Sustanon)FDA Link
01/2017 |
1 | Amino AcidsFDA Link
01/2017 |
1 | AndrogensIBA
01/2017 |
1 | thiamine triphosphorate (TTP)IBA
01/2016 |
1 | Cyclin-Dependent Kinase Inhibitor p16IBA
01/2016 |
1 | Cetuximab (Erbitux)FDA Link
01/2016 |
1 | palbociclibIBA
01/2016 |
1 | Retinoblastoma ProteinIBA
01/2016 |
1 | Cyclin-Dependent Kinase 4IBA
01/2016 |
1 | MicellesIBA
11/2015 |
1 | pyrazoleIBA
02/2015 |
1 | liposomal doxorubicin (Doxil)FDA Link
08/2014 |
1 | temsirolimusFDA Link
08/2014 |
1 | 1-dodecylpyridoxal (PLD)IBA
08/2014 |
1 | AmphiregulinIBA
04/2014 |
1 | Deoxycholic Acid (Sodium Deoxycholate)IBA
04/2014 |
1 | Mitogen-Activated Protein KinasesIBA
04/2014 |
1 | Thymidylate SynthaseIBA
01/2014 |
1 | cobaltous chloride (cobalt(II)chloride)IBA
09/2013 |
1 | Biological ProductsIBA
01/2013 |
1 | Codon (Codons)IBA
01/2013 |
1 | epoxomicinIBA
09/2012 |
1 | UK 101IBA
09/2012 |
1 | Molecular Probes (Molecular Probe)IBA
12/2011 |
1 | Oxaliplatin (Eloxatin)FDA LinkGeneric
12/2008 |
1 | CamptothecinIBA
12/2008 |
1 | Organic Anion TransportersIBA
08/2007 |
1 | Member 11 Subfamily B ATP Binding Cassette TransporterIBA
08/2007 |
1 | Proteins (Proteins, Gene)FDA Link
08/2007 |
1 | Pravastatin (Pravachol)FDA LinkGeneric
08/2007 |